We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Update on the ICUD-SIU consultation on multi-parametric magnetic resonance imaging in localised prostate cancer.
- Authors
Barret, Eric; Turkbey, Baris; Puech, Philippe; Durand, Matthieu; Panebianco, Valeria; Fütterer, Jurgen J.; Renard-Penna, Raphaële; Rouvière, Olivier
- Abstract
Introduction: Prostate cancer (PCa) imaging is a rapidly evolving field. Dramatic improvements in prostate MRI during the last decade will probably change the accuracy of diagnosis. This chapter reviews recent current evidence about MRI diagnostic performance and impact on PCa management.Materials and methods: The International Consultation on Urological Diseases nominated a committee to review the literature on prostate MRI. A search of the PubMed database was conducted to identify articles focussed on MP-MRI detection and staging protocols, reporting and scoring systems, the role of MP-MRI in diagnosing PCa prior to biopsy, in active surveillance, in focal therapy and in detecting local recurrence after treatment.Results: Differences in opinion were reported in the use of the strength of magnets [1.5 Tesla (T) vs. 3T] and coils. More agreement was found regarding the choice of pulse sequences; diffusion-weighted MRI (DW-MRI), dynamic contrast-enhanced MRI (DCE MRI), and/or MR spectroscopy imaging (MRSI) are recommended in addition to conventional T2-weighted anatomical sequences. In 2015, the Prostate Imaging Reporting and Data System (PI-RADS version 2) was described to standardize image acquisition and interpretation. MP-MRI improves detection of clinically significant PCa (csPCa) in the repeat biopsy setting or before the confirmatory biopsy in patients considering active surveillance. It is useful to guide focal treatment and to detect local recurrences after treatment. Its role in biopsy-naive patients or during the course of active surveillance remains debated.Conclusion: MP-MRI is increasingly used to improve detection of csPCa and for the selection of a suitable therapeutic approach.
- Subjects
MAGNETIC resonance imaging; PROSTATE cancer; CONTRAST-enhanced magnetic resonance imaging; IMAGE analysis; SPECTRAL imaging; URINARY organ diseases
- Publication
World Journal of Urology, 2019, Vol 37, Issue 3, p429
- ISSN
0724-4983
- Publication type
Article
- DOI
10.1007/s00345-018-2395-3